Literature DB >> 16714399

In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology.

M van Seters1, F J W ten Kate, M van Beurden, R H M Verheijen, C J L M Meijer, M P M Burger, T J M Helmerhorst.   

Abstract

BACKGROUND: Differentiated vulvar intraepithelial neoplasia (VIN) is presumed to be the precursor of invasive squamous cell carcinoma (SCC) of the vulva. It is commonly assumed that differentiated VIN is related to lichen sclerosus (LS). However, evidence for this is limited to a small number of studies describing epithelial alterations adjacent to vulvar SCC. AIM: To study the histology and human papillomavirus (HPV) status in patients with a history of both LS and VIN without coexistent SCC.
METHODS: Original biopsy specimens and surgical specimens of patients retrieved from the pathology files were revised for the presence of LS, VIN and (early) invasive SCC, specifically focused on the two different types of VIN: differentiated and undifferentiated. Thereafter, VIN lesions were tested for the presence of HPV DNA.
RESULTS: Twenty-seven patients fulfilled the criteria for LS and VIN without SCC. In all 27 patients, LS was found to be related to undifferentiated VIN. Grading yielded the following results: VIN 1 (n=10), VIN 2 (n=11) and VIN 3 (n=6). Additionally, VIN lesions from 26 patients could be tested for the presence of HPV DNA. HPV DNA, predominantly type 16, was present in 8 (31%) of them. Seven of these eight patients had VIN 2 or 3. During follow-up, three patients progressed to (early) invasive carcinoma. In two of these patients, differentiated VIN was observed overlying early invasive SCC.
CONCLUSIONS: VIN related to LS without coexisting SCC is likely to be undifferentiated, in contrast to what was previously thought. HPV DNA was demonstrated in 31% of the lesions, and was strongly related to high-grade VIN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714399      PMCID: PMC1994523          DOI: 10.1136/jcp.2005.031989

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  33 in total

1.  Clinicopathologic analysis of 370 cases of vulvar intraepithelial neoplasia. Italian Study Group on Vulvar Disease.

Authors: 
Journal:  J Reprod Med       Date:  1996-09       Impact factor: 0.142

2.  Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases.

Authors:  C Vilmer; B Cavelier-Balloy; C Nogues; M Trassard; V Le Doussal
Journal:  Eur J Gynaecol Oncol       Date:  1998       Impact factor: 0.196

Review 3.  Epithelial alterations adjacent to invasive squamous carcinoma of the vulva.

Authors:  N Gómez Rueda; A García; S Vighi; M G Belardi; L Cardinal; G di Paola
Journal:  J Reprod Med       Date:  1994-07       Impact factor: 0.142

4.  Human papillomaviruses and multifocal genital neoplasia.

Authors:  U Hording; S Daugaard; J Junge; F Lundvall
Journal:  Int J Gynecol Pathol       Date:  1996-07       Impact factor: 2.762

5.  Vulvar intraepithelial neoplasia of low grade: a challenging diagnosis.

Authors:  L Micheletti; M Barbero; M Preti; M C Zanotto Valentino; B Chiringhello; M Pippione
Journal:  Eur J Gynaecol Oncol       Date:  1994       Impact factor: 0.196

6.  Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin.

Authors:  M J Kagie; G G Kenter; Y Zomerdijk-Nooijen; J Hermans; E Schuuring; P J Timmers; J B Trimbos; G J Fleuren
Journal:  Gynecol Oncol       Date:  1997-11       Impact factor: 5.482

7.  Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study.

Authors:  P Carli; A Cattaneo; A De Magnis; A Biggeri; G Taddei; B Giannotti
Journal:  Eur J Cancer Prev       Date:  1995-12       Impact factor: 2.497

Review 8.  Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia.

Authors:  J A Carlson; R Ambros; J Malfetano; J Ross; R Grabowski; P Lamb; H Figge; M C Mihm
Journal:  Hum Pathol       Date:  1998-09       Impact factor: 3.466

9.  Heterogeneous etiology of squamous carcinoma of the vulva.

Authors:  C L Trimble; A Hildesheim; L A Brinton; K V Shah; R J Kurman
Journal:  Obstet Gynecol       Date:  1996-01       Impact factor: 7.661

10.  Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus.

Authors:  M van Beurden; F J ten Kate; H L Smits; R J Berkhout; A J de Craen; N van der Vange; F B Lammes; J ter Schegget
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

View more
  5 in total

Review 1.  Vulvar cancer: a review for dermatologists.

Authors:  Anastasiya Atanasova Chokoeva; Georgi Tchernev; Elena Castelli; Elisabetta Orlando; Shyam B Verma; Markus Grebe; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2015-05-01

Review 2.  New Directions in Vulvar Cancer Pathology.

Authors:  Anthony Williams; Sheeba Syed; Shireen Velangi; Raji Ganesan
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

Review 3.  Vulvar lichen sclerosus in the elderly: pathophysiology and treatment update.

Authors:  Natalie A Saunders; Hope K Haefner
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 4.  Vulvar skin disorders throughout lifetime: about some representative dermatoses.

Authors:  Jean Doyen; Stéphanie Demoulin; Katty Delbecque; Frédéric Goffin; Frédéric Kridelka; Philippe Delvenne
Journal:  Biomed Res Int       Date:  2014-01-08       Impact factor: 3.411

5.  Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation.

Authors:  Debra S Heller; Tania Day; Jill I Allbritton; James Scurry; Gianluigi Radici; Kathryn Welch; Mario Preti
Journal:  J Low Genit Tract Dis       Date:  2021-01-01       Impact factor: 3.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.